Back to Journals » Infection and Drug Resistance » Volume 17

Two Cases of Listeria monocytogenes-Induced Infective Endocarditis

Authors Tang M, Lu X, Li Y, Chen Y, Xie Y

Received 11 July 2024

Accepted for publication 7 October 2024

Published 21 October 2024 Volume 2024:17 Pages 4567—4575

DOI https://doi.org/10.2147/IDR.S473359

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Dr Sandip Patil



Mengli Tang,1,* Xingbing Lu,1,* Yuxiao Li,2 Yuzuo Chen,1 Yi Xie1

1Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China; 2West China School of Medicine, Sichuan University, Chengdu, Sichuan, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Yi Xie, Department of Laboratory Medicine, West China Hospital, Sichuan University, Guoxue Lane37, Chengdu, Sichuan, People’s Republic of China, Tel +86-028-85422618, Email [email protected]

Abstract: Listeria monocytogenes is a prevalent gram-positive intracellular zoonotic pathogen that is frequently associated with foodborne illnesses and opportunistic infections. This bacterium is responsible for causing various clinical manifestations, including bacteremia, meningitis, and encephalitis, and is primarily transmitted through contaminated food consumption. This study presents two cases of severe endocarditis in patients with heart valve disease caused by L. monocytogenes. Infection was confirmed by blood culture and pathogen culture of the valve pus. Early detection, clinical suspicion, and appropriate treatment are crucial for improving the prognosis of patients with listeriosis. The combination of ampicillin and aminoglycosides remains the most effective treatment for listeriosis.

Keywords: infective endocarditis, Listeria monocytogenes, heart valve disease

Introduction

Infective endocarditis (IE) is a microbial infection affecting the heart valves or endocardial surface, often resulting in the formation of vegetation on the valves and potentially leading to myocardial abscesses, significant valve regurgitation, systemic embolism, and may ultimately culminate in heart failure or mortality.1 IE initiates with the adhesion of bacteria to tissues within the circulatory system. This process is facilitated by various predisposing factors, including rheumatic heart disease, prosthetic heart valves, residual intra-cardiac shunts, congenital heart anomalies, and ventricular assist devices.2 Listeria monocytogenes, a gram-positive zoonotic intracellular pathogen, is a notable foodborne bacterium with conditional pathogenicity that causes listeriosis.3 Clinical manifestations of L. monocytogenes infection include bacteremia, meningitis, and encephalitis primarily transmitted through contaminated food sources, resulting in a high hospitalization rate and a mortality rate near 50%.4 The infection primarily affects elderly individuals, pregnant women, patients with malignancies, immunosuppressed individuals, and those with compromised immune systems while also causing self-limiting febrile gastroenteritis in healthy individuals.5 However, cases of IE attributed to L. monocytogenes are infrequent. In this study, we present two instances of heart valve disease induced by L. monocytogenes.

Case 1

A 62-year-old male patient was admitted to the hospital due to sudden onset of blurred vision in his right eye persisting for 20 days. Upon physical examination, the patient exhibited a temperature of 36.3°C and presented with symptoms of acute illness, including an enlarged cardiac sector, arrhythmia, a systolic blowing murmur in the apical region, and a mid-to-late diastolic rumbling murmur. The patient had a 12-year history of heart valve disease with postactivity cardiac fatigue that worsened two years ago and had been managed with digoxin, aspirin, and spironolactone over an extended period. Transesophageal echocardiography revealed irregular thickening and severe stenosis of the mitral valve, severe regurgitation, irregular thickening of the aortic valve with mild stenosis, mild regurgitation of the tricuspid valve, and a large left atrium (Figure 1). An electrocardiogram (ECG) indicated atrial fibrillation with left ventricular high voltage at a rate of 77 beats per minute. Laboratory tests conducted upon admission revealed significant elevations in the leukocyte count (10.71×109/L), neutrophil granulocyte count (7.83×109/L), C-reactive protein level (47.80 mg/L), and sedimentation rate (68.0 mm/h), which were indicative of inflammation. Additionally, the N-terminal pro-B-type natriuretic peptide (NT-ProBNP) concentration was 2007 ng/L, the troponin T concentration was 117.8 ng/L, the lactate dehydrogenase concentration was 265 IU/L, and the hydroxybutyrate dehydrogenase concentration was 221 IU/L, all of which showed varying degrees of increase.

Figure 1 (AF) Transesophageal echocardiography results before and after surgery. (A) Enlarged left atrium with normal left ventricular systolic function; (B and C) The mitral valve exhibited irregular thickening and severe stenosis with severe regurgitation, along with irregular thickening of the aortic valve; (D) The presence of echogenic flopping on the aortic valve with mild stenosis and mild tricuspid regurgitation; (E and F) No notable irregularities were observed in prosthetic bioprosthetic valve function or left ventricular systolic function measurements after surgery.

On the first day of hospitalization, the patient was suspected to have infective endocarditis following diagnostic evaluations. Consequently, two vials of blood culture were sent for examination, and a dose of 15 mg/kg vancomycin hydrochloride was administered every 12 hours (q12h) as an empirical treatment. On the third day of hospitalization, the patient underwent mitral valve and aortic valve replacement and tricuspid valvuloplasty. During the surgical intervention, approximately 50 mL of yellowish fluid was observed, with no pericardial adhesion noted. The heart exhibited enlargement, particularly affecting the left side. The mitral valve leaflet displayed thickening, calcification, and adhesion at the junction, resulting in severe stenosis and insufficient closure. The aortic and right coronary valves showed mild narrowing with a 1 cm × 1 cm vegetation, while the tricuspid annulus was enlarged with mild closure insufficiency. Furthermore, a 2 cm × 2 cm abscess was identified at the junction of the left coronary sinus, and pus samples were collected for further analysis.

After 22 hours, the blood culture yielded a positive result, with the bacterial colonies observed on the blood agar exhibiting characteristics of being small, white, and smooth (Figure 2). L. monocytogenes was determined through mass spectrometry analysis, confirming the diagnosis of IE caused by this pathogen. In vitro drug sensitivity tests revealed that L. monocytogenes was sensitive to ampicillin, erythromycin, meropenem, and penicillin G but resistant to cotrimoxazole and sulfamethoxazole-trimethoprim. The treatment of Listeria endocarditis involved the administration of 2 g of ampicillin q8h. The patient experienced recurrent fever during the treatment period, with a peak temperature of 38.5°C. Consequently, further efforts were undertaken to administer 1000 mg of meropenem q8h or 3000 mg of piperacillin-tazobactam sodium for antimicrobial therapy at different stages. Ocular examination did not reveal any significant lesions in the right eye, suggesting that the observed blurred vision may be attributed to the heart condition.

Figure 2 Colonies of L. monocytogenes on blood agar and mass spectrometry results. (A) Colonies are small, white, and smooth on the blood agar. (B) Diagram of mass spectrum peaks, with the color blue indicating the strain that was detected.

After 5 weeks of active anti-infection therapy, the patient exhibited a normal body temperature and improved symptoms. Examination of cerebrospinal fluid and blood pathogen cultures yielded negative results. Markers of infection returned to normal levels; imaging examinations, including magnetic resonance imaging (MRI) of the head and computed tomography (CT) scanning, revealed no signs of infection, indicating successful treatment of the patient’s Listeria endocarditis. Furthermore, transesophageal echocardiography revealed normal left ventricular systolic function and proper functioning of bioprosthetic valves, with no significant postoperative complications (Figure 1). The patient was discharged on the 39th day with a favorable recovery outcome. Subsequent follow-up over a 2-year period postoperation revealed no recurrence of the condition.

Case 2

A 38-year-old male patient was admitted to the hospital because of avulsion of aortic valve prosthesis. The individual had previously undergone aortic valve and root replacement surgery eight years before due to aortic aneurysm. Upon admission, the patient exhibited stable vital signs, with a normal heart boundary and no abnormalities in the precordial area. A systolic murmur was detected in the aortic valve region, along with arrhythmia and irregular heart sounds. Transesophageal echocardiography revealed a separation between the artificial aortic valve and the native aortic annulus, accompanied by considerable regurgitation surrounding the prosthetic valve (Figure 3). Computed tomography (CT) results indicated left ventricular enlargement and mild pericardial effusion (Figure 4). ECG revealed atrioventricular block and ST-T changes. Initial laboratory tests revealed significant increases in leukocyte count (10.04×109/L), neutrophil granulocyte count (7.11×109/L), C-reactive protein level (43.40 mg/L) and sedimentation rate (48.0 mm/h), which are indicative of inflammation. Concentration of NT-ProBNP (28163 ng/L) and troponin T (279.3 ng/L) reached critical values.

Figure 3 (AD) Transesophageal echocardiography results before and after surgery. (A) Artificial aortic valve detached from the intrinsic aortic annulus. (B) Significant paravalvular regurgitation. (C) Artificial aortic valve was functioning normally. (D) Normal blood flow observed in the artificial ascending aorta.

Figure 4 Computed tomography (CT) scans were performed during both the infection and recovery stages. (A and B) During the infection phase, CT revealed left ventricular enlargement and mild pericardial effusion. (C and D) During the recovery phase, the aortic valve orifice was free of obstruction, and there was a decrease in the accumulation of fluid in the pericardial cavity.

On the seventh day following admission, the leukocyte count (11.29×109/L) and predominant neutrophilic nucleated granulocyte count (10.24×109/L) indicated a worsening infection. Blood cultures revealed the presence of gram-positive bacilli identified as L. monocytogenes, which were sensitive to ampicillin, meropenem, penicillin G, and the compound sulfamethoxazole. Vancomycin (15 mg/kg, q12h) was administered for initial anti-infection treatment, and the medication regimen was changed to ampicillin (2 g, q8h) after detecting L. monocytogenes. Modified cabrol surgery was performed on the tenth day. Transesophageal echocardiography revealed extensive adhesion in the pericardium and significant tissue proliferation around the ascending aorta with pus at the root. The artificial mechanical valve frame was completely removed, and proliferation of fibrous tissue formed under the original valve annulus. Purulent samples were collected and subjected to microbiological testing.

After surgery, the patient experienced fever along with elevated levels of inflammatory markers and subsequent treatment with piperacillin-tazobactam at a dosage of 4500 mg q8h or meropenem at a dosage of 1000 mg q8h for antimicrobial purposes at various stages. Afterward, the patient’s health condition remained stable, with no signs of infection. On the 25th day, a permanent dual chamber pacemaker was implanted. The patient was discharged on the 30th day. A follow-up examination conducted 4 months later indicated that the artificial aortic valve was functioning normally, with normal blood flow observed in the artificial ascending aorta (Figure 3). CT imaging revealed a significant decrease in localized fluid accumulation in the pericardial cavity (Figure 4). Subsequent follow-up over an 11-month period postoperation revealed no recurrence of the condition.

Discussion

Endocarditis caused by L. monocytogenes is a rare but serious disease characterized by a high fatality rate. Among the aforementioned patients, two had a prolonged history of heart valve disease and were predisposed to L. monocytogenes infection. Two patients had chronic postactivity cardiac fatigue without significant fever, localized pain or other typical symptoms of endocarditis on admission, which was consistent with limited systemic inflammation associated with invasive listeriosis.6 Presently, the diagnosis of listeriosis relies on the isolation and identification of L. monocytogenes from biological specimens, including blood cultures or cerebrospinal fluid.7 In our patients, L. monocytogenes was detected simultaneously in heart valve pus obtained intraoperatively and in peripheral blood cultures, elevated inflammatory markers, and recurrent fever, which led to the final determination of heart valve disease combined with L. monocytogenes-induced endocarditis. Studies have confirmed that endovascular infections such as endocarditis are not linked to specific L. monocytogenes clones and that genomic sequence diversity reflects the overall distribution of isolates causing sporadic listeriosis.8 In cases where a heart murmur is not readily apparent, IE may be obscured by the primary infection, leading to a heightened risk of misdiagnosis. It should be differentiated from influenza, acute arthritis, acute purulent meningitis, acute pyelonephritis, etc. Artificial valve replacement surgery, hemodialysis, or congenital heart disease correction surgery all increase the risk of endocardial infection.9 For patients with these risk factors, attention should be paid to changes in cardiac auscultation, skin bleeding points, and embolism. An echocardiogram should be performed, and blood samples should be obtained to check for the presence of bacteria.

In this study, we examined cases of IE attributed to L. monocytogenes as reported in the PubMed database over the preceding five-year period (Table 1). The infected patients were predominantly male (71.4%, 5/7), with an average age of 60.4 ± 17.5 years. Symptoms commonly presented upon admission included sudden encephalopathy (42.9%, 3/7) and acute myocardial infarction with respiratory distress (28.6%, 2/7). A large majority of the patients had a prior history of heart disease or heart valve surgery (85.7%, 6/7). Upon detection of L. monocytogenes, patients exhibited various infection-related symptoms, such as elevated white blood cell count and proportion of multinucleated cells (57.1%, 4/7), increased levels of C-reactive protein (42.9%, 3/7), and fever (42.9%, 3/7). The most frequently administered antibiotics for treatment were ampicillin and gentamicin (57.1%, 4/7). Following the infection, two patients underwent surgical treatment after the infection, and two patients ultimately died (28.6%). The mortality rate among patients diagnosed with IE has been documented to be approximately 30%.10 A study examining 100 patients with L. monocytogenes endocarditis revealed that these patients had variable clinical presentations and that vascular phenomena were prevalent but caused milder symptoms with a lower incidence of fever and localized pain than other pathogens, such as Staphylococcus aureus, Streptococcus spp. and Enterobacteriaceae.3,6,7 The main predisposing factors associated with this condition include immunodeficiency, valvular disease, prosthetic devices, hypertrophic cardiomyopathy, and a history of endocarditis. Another study on 71 cases of L. monocytogenes-associated endovascular infections indicated that the presence of prosthetic devices, including those related to valvular, intracardiac, or vascular structures, was significantly correlated with an increased incidence of endocarditis and vascular infections among patients experiencing bacteremia.8 Aortic involvement was most frequently observed in patients with congenital valvular endocarditis, while mitral valve involvement was common in individuals with prosthetic hearts.3 In patients with prosthetic valve endocarditis, the combination of antibiotic therapy and valve replacement surgery has demonstrated an increased rate of successful treatment outcomes.11 Notably, patients who present with endocarditis concurrent with L. monocytogenes encephalitis infection often had a poor prognosis, leading to a significant increase in mortality rates due to the rapid progression of the disease.12,13

In cases of IE where patients present with acute symptoms, intravenous antibiotic therapy should be started immediately after obtaining blood samples for culture.14 The selection of antibiotics, along with their dosage and duration of administration, is contingent upon the minimal inhibitory concentrations (MICs) identified in blood cultures. Treatment strategies are informed by clinical presentations and serological assessments, and early surgical intervention is advisable in cases with significant valve dysfunction and a substantial presence of vegetations.15 Given the rarity of these infections, there are no established treatment protocols for L. monocytogenes endocarditis or vascular infections, with most patients typically receiving a combination of amoxicillin and aminoglycoside. The recommended duration of amoxicillin therapy is 6–8 weeks for prosthetic valve endocarditis and at least 4 weeks for native valve endocarditis, and the bactericidal efficacy of this combination has been demonstrated.7,8 According to the Sanford Guide for Antimicrobial Therapy (43rd edition), the standard treatment regimen for L. monocytogenes disease is ampicillin and gentamicin combined with methomycin/sulfamethoxazole or meropenem in cases of penicillin allergy.4 The combinations of ampicillin + ceftriaxone and ampicillin + daptomycin were each noted to have synergistic activity against L. monocytogenes endocarditis isolates according to checkerboard assays.16 In the cases discussed, patients received ampicillin for the treatment of L. monocytogenes endocarditis. Subsequently, piperacillin and meropenem were utilized during different treatment phases in accordance with established clinical guidelines and the results of drug sensitivity testing.

Table 1 Reported Cases of Infective Endocarditis Caused by L. Monocytogenes in the Past 5 Years

In summary, endocarditis associated with L. monocytogenes is rare, yet healthcare providers should be cognizant of this severe and specific complication. Clinicians must thoroughly assess potential L. monocytogenes-associated endocarditis infections and promptly administer aggressive combined antimicrobial and surgical interventions. Therefore, timely and appropriate initiation of antimicrobial therapy is crucial for managing this disease and enhancing the clinical outlook for patients, particularly those who are elderly, have tumors, or suffer from immunodeficiencies. Diagnostic and therapeutic measures for listeriosis heavily rely on pathogenic bacterial culture and antimicrobial susceptibility test. Clinicians should increase the frequency of specimen collection and blood culture while ensuring an adequate treatment regimen. Our study provides an important perspective on L. monocytogenes-related IE, and we hope that the findings will provide a reference for clinicians to diagnose and treat L. monocytogenes-related IE in a timely manner.

Conclusion

This study reports the diagnostic and therapeutic course of L. monocytogenes as an example of endocarditis occurring in patients with a history of heart valve disease. Echocardiography serves as a diagnostic tool for the verification of implants, abscesses, valve perforations, or the detachment of artificial valves. Additionally, the identification of microorganisms and their susceptibility to antibiotics is essential for informing treatment strategies. The selection of antibiotics, along with their dosage and duration of administration, is contingent upon the MICs identified in blood cultures. The most effective treatment for listeriosis involves a combination therapy regimen comprising ampicillin and aminoglycosides.

Abbreviations

IE, infective endocarditis; ECG, electrocardiogram; NT-ProBNP, N-terminal pro-B-type natriuretic peptide; MRI, magnetic resonance imaging; CT, computed tomography; MICs, minimal inhibitory concentrations.

Ethical Approval and Informed Consent

The documentation and publication of the case were approved by the Ethics Review Committee of West China Hospital, Sichuan University (Approval Number: 20231974). Written informed consent for publication of their details was obtained from the patients. The subjects’ rights were adequately protected, and there was no potential risk to the subjects.

Acknowledgments

We thank patients who participated in this study. We also thank Dr. Xueping Xiao for her consultation on cardiac ultrasound.

Author Contributions

All authors made a significant contribution to the work reported, whether in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; agreed on the journal to which the article has been submitted; and agreed to be accountable for all aspects of the work.

Disclosure

The authors have no conflicts of interest to declare in this work.

References

1. Hubers SA, DeSimone DC, Gersh BJ, Anavekar NS. Infective endocarditis: a contemporary review. Mayo Clin Proc. 2020;95(5):982–997. doi:10.1016/j.mayocp.2019.12.008

2. Cahill TJ, Baddour LM, Habib G, et al. Challenges in infective endocarditis. J Am Coll Cardiol. 2017;69(3):325–344. doi:10.1016/j.jacc.2016.10.066

3. Macleod J, Beeton ML, Blaxland J. An exploration of Listeria monocytogenes, its influence on the UK food industry and future public health strategies. Foods. 2022;11(10):1456. doi:10.3390/foods11101456

4. Lu X, Yang H, Wang Y, Xie Y. Analysis of clinical and microbiological features of Listeria monocytogenes infection. Infect Drug Resist. 2023;16:2793–2803. doi:10.2147/IDR.S408089

5. Matle I, Mbatha KR, Madoroba E. A review of Listeria monocytogenes from meat and meat products: epidemiology, virulence factors, antimicrobial resistance and diagnosis. Onderstepoort J Vet Res. 2020;87(1). doi:10.4102/ojvr.v87i1.1869

6. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169(5):463–473. doi:10.1001/archinternmed.2008.603

7. Randrianarisoa RMF, Ramanandafy H, Mania A, et al. Listeria endocarditis and spondylodiscitis: a case report and review of the literature. Clin Case Rep. 2022;10(5):e05899. doi:10.1002/ccr3.5899

8. Shoai-Tehrani M, Pilmis B, Maury MM, et al. Listeria monocytogenes-associated endovascular infections: a study of 71 consecutive cases. J Infect. 2019;79(4):322–331. doi:10.1016/j.jinf.2019.07.013

9. Sebastian SA, Co EL, Mehendale M, Sudan S, Manchanda K, Khan S. Challenges and updates in the diagnosis and treatment of infective endocarditis. Curr Probl Cardiol. 2022;47(9):101267. doi:10.1016/j.cpcardiol.2022.101267

10. McLaughlin L, Doulamis IP, Briasoulis A, Kampaktsis PN. Increasing mortality rates from infective endocarditis among young US residents. J Intern Med. 2023;293(2):262–263. doi:10.1111/joim.13579

11. Fernández Guerrero ML, Rivas P, Rábago R, Núñez A, de Górgolas M, Martinell J. Prosthetic valve endocarditis due to Listeria monocytogenes. Report of two cases and reviews. Int J Infect Dis. 2004;8(2):97–102. doi:10.1016/j.ijid.2003.06.002

12. Li N, Huang HQ, Zhang GS, Hua W, Shen HH. Encephalitis caused by Listeria monocytogenes in a healthy adult male in China: a case report. Medicine. 2019;98(25):e16145. doi:10.1097/MD.0000000000016145

13. Láinez-Ramos Bossini AJ, Redruello-Guerrero P, Martínez-Barbero JP, Gutiérrez-Jiménez P, Gutiérrez-Jiménez C, Rivera-Izquierdo M. Epidemiology, clinical and imaging features of rhombencephalitis caused by L. monocytogenes. A retrospective observational study. Rev Neurol. 2023;76(12):385–390. doi:10.33588/rn.7612.2023020

14. Li M, Kim JB, Sastry BKS, Chen M. Infective endocarditis. Lancet. 2024;404(10450):377–392. doi:10.1016/S0140-6736(24)01098-5

15. Jussli-Melchers J, Friedrich C, Mandler K, et al. Risk factor analysis for 30-day mortality after surgery for infective endocarditis. Thorac Cardiovasc Surg. 2024. doi:10.1055/s-0044-1779709

16. Kumaraswamy M, Do C, Sakoulas G, et al. Listeria monocytogenes endocarditis: case report, review of the literature, and laboratory evaluation of potential novel antibiotic synergies. Int J Antimicrob Agents. 2018;51(3):468–478. doi:10.1016/j.ijantimicag.2017.12.032

17. Shobayo A, Kommineni K, Sharma K. Resolution of atrial-ventricular block secondary to Listeria monocytogenes with antimicrobials. IDCases. 2019;18:e00646. doi:10.1016/j.idcr.2019.e00646

18. Zhao J, Yang J, Chen W, et al. Acute myocardial infarction as the first sign of infective endocarditis: a case report. J Int Med Res. 2020;48(12):300060520980598. doi:10.1177/0300060520980598

19. Scheggi V, Marchionni N, Stefàno PL. Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report. Eur Heart J Case Rep. 2021;5(9):ytab341. doi:10.1093/ehjcr/ytab341

20. Badar F, Bhuiyan R, Nabeel S. A case of Listeria monocytogenes infective endocarditis. Case Rep Infect Dis. 2022;2022:5958017. doi:10.1155/2022/5958017

21. Marschner M, Hausdorf C, Schlatterer K. Listeria endocarditis. Inn Med. 2023;64(3):284–287. doi:10.1007/s00108-022-01433-6

22. Mohan SA, Sufyaan Z. Listeria monocytogenes cerebritis and infective endocarditis in an immunocompetent adult: a rare clinical manifestation. Case Rep Infect Dis. 2023;2023:7405556. doi:10.1155/2023/7405556

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.